Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells

Journal of Pineal Research

Volumn 53, Issue 2, 2012, Pages 180-187

  Wang, Juntao ^a   Hao, Hongbo ^b   Yao, Linli ^c   Zhang, Xiaodan ^a   Zhao, Shidou ^d   Ling, Eng Ang ^e   Hao, Aijun ^c   Li, Gang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANDONG UNIVERSITY   (China)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

glioma; invasion; melatonin; migration; NF B; ROS

Indexed keywords

GELATINASE A; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ARTICLE; CELL INVASION; CELL MIGRATION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATIVE STRESS; PINEAL BODY; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FREE RADICALS; GLIOMA; HUMANS; MELATONIN; NF-KAPPA B; OXIDATIVE STRESS; PYRROLIDINES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THIOCARBAMATES;

EID: 84865038800     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.00985.x     Document Type: Article

References (47)

1. Louis DN, Ohgaki H, Wiestler OD, et al., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
2. Giese A, Westphal M,. Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 2001; 127: 217-225.
3. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
4. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
5. Foulkes NS, Borjigin J, Snyder SH, et al., Rhythmic transcription: the molecular basis of circadian melatonin synthesis. Trends Neurosci 1997; 20: 487-492.
6. Lanoix D, Beghdadi H, Lafond J, et al., Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008; 45: 50-60.
7. Brzezinski A,. Melatonin in humans. N Engl J Med 1997; 336: 186-195.
8. Hardeland R,. Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci 2008; 65: 2001-2018.
9. Dubocovich ML,. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med 2007; 8 (Suppl 3): 34-42.
10. Haldar C, Ahmad R,. Photoimmunomodulation and melatonin. J Photochem Photobiol, B 2010; 98: 107-117.
11. Kaur C, Ling EA,. Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem 2008; 15: 3068-3080.
12. Mayo JC, Sainz RM, Tan DX, et al., Melatonin and Parkinson's disease. Endocrine 2005; 27: 169-178.
13. Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, et al., Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 2011; 52: 167-202.
14. Cervantes M, Morali G, Letechipia-Vallejo G,. Melatonin and ischemia-reperfusion injury of the brain. J Pineal Res 2008; 45: 1-7.
15. Tan DX, Manchester LC, Sainz RM, et al., Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res 2005; 39: 185-194.
16. Tan DX, Reiter RJ, Manchester LC, et al., Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-197.
17. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
18. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
19. Reiter RJ, Tan DX, Mayo JC, et al., Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50: 1129-1146.
20. Reiter RJ,. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359-384.
21. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, et al., Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 2010; 17: 4462-4481.
22. Cos S, Fernandez R, Guezmes A, et al., Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58: 4383-4390.
23. Ortiz-Lopez L, Morales-Mulia S, Ramirez-Rodriguez G, et al., ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009; 46: 15-21.
24. Ramirez-Rodriguez G, Ortiz-Lopez L, Benitez-King G,. Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C. J Pineal Res 2007; 42: 180-190.
25. Bellon A, Ortiz-Lopez L, Ramirez-Rodriguez G, et al., Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase. J Pineal Res 2007; 42: 214-221.
26. Martin V, Herrera F, Carrera-Gonzalez P, et al., Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 2006; 66: 1081-1088.
27. Jia DY, Du ZH, Liu SM, et al., c-Abl is involved in high glucose-induced apoptosis in embryonic E12.5 cortical neural progenitor cells from the mouse brain. J Neurochem 2008; 106: 1720-1730.
28. Wang J, Li G, Wang Z, et al., High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes. Neuroscience 2011; 202: 58-68.
29. Liu Q, Li G, Li R, et al., IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 2010; 100: 165-176.
30. Yang YM, Feng AL, Zhou CJ, et al., Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression. Cancer Sci 2011; 102: 1264-1271.
31. Sabeh F, Shimizu-Hirota R, Weiss SJ,. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009; 185: 11-19.
32. Szatrowski TP, Nathan CF,. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-798.
33. Tobar N, Villar V, Santibanez JF,. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 2010; 340: 195-202.
34. Binker MG, Binker-Cosen AA, Gaisano HY, et al., TGF-beta1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-kappaB/IL-6/MMP-2. Biochem Biophys Res Commun 2011; 405: 140-145.
35. Schreck R, Meier B, Mannel DN, et al., Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175: 1181-1194.
36. Das A, Belagodu A, Reiter RJ, et al., Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008; 45: 117-124.
37. Kessenbrock K, Plaks V, Werb Z,. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
38. Hussain SP, Hofseth LJ, Harris CC,. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
39. Montero AJ, Jassem J,. Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs 2011; 71: 1385-1396.
40. Ozben T,. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 2007; 96: 2181-2196.
41. Brar SS, Corbin Z, Kennedy TP, et al., NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 2003; 285: C353-C369.
42. Yang C, Jo SH, Csernus B, et al., Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. Am J Pathol 2007; 170: 722-732.
43. Ushio-Fukai M,. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 2006; 71: 226-235.
44. Ushio-Fukai M, Alexander RW,. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004; 264: 85-97.
45. Ushio-Fukai M, Nakamura Y,. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008; 266: 37-52.
46. Kamata H, Hirata H,. Redox regulation of cellular signalling. Cell Signal 1999; 11: 1-14.
47. Lin A, Karin M,. NF-kappaB in cancer: a marked target. Semin Cancer Biol 2003; 13: 107-114.